Cidara Therapeutics, Inc.
USD221.38
+0.00 (+0.00%)
CEO
Jeffrey L. Stein
IPO Date
2015-04-15
Sector
Healthcare
Industry
Biotechnology
Exchange
NASDAQ
Country
US
Open
$221.38
Prev. Close
$221.38
Day Low
$221.38
Day High
$221.38
52W Low
$15.22
52W High
$221.42
Market Cap
$5.61B
Volume
2.69M
| -3.0 |
| 31 Dec 2022 | FY | 100.0% | -52.1% | 232.6% | -70.7% | -0.08 | 1.09 | -1.6 |
| 31 Dec 2021 | FY | -47.4% | -85.7% | -196.9% | -56.4% | 0.23 | 2.11 | -1.6 |
| 31 Dec 2020 | FY | 100.0% | -597.6% | -673.0% | -119.3% | 0.74 | 1.48 | -1.2 |
| 31 Dec 2019 | FY | -121.9% | -196.5% | -108.6% | -59.6% | 0.31 | 2.18 | -2.8 |
| 31 Dec 2018 | FY | 0.0% | 0.0% | -99.8% | -74.6% | 0.17 | 3.88 | -1.0 |
| 31 Dec 2017 | FY | 0.0% | 0.0% | -93.3% | -70.5% | 0.17 | 6.43 | -2.1 |
| 31 Dec 2016 | FY | 0.0% | 0.0% | -54.6% | -45.0% | 0.11 | 11.83 | -3.1 |
| 31 Dec 2015 | FY | 0.0% | 0.0% | -31.0% | -29.3% | 0.00 | 18.11 | -7.3 |
| -7.4 |
| 31 Mar 2025 | Q1 | 0.0% | 0.0% | -16.6% | -12.2% | 0.02 | 3.87 | -3.3 |
| 31 Dec 2024 | Q4 | 0.0% | 0.0% | -32.0% | -24.4% | 0.02 | 4.25 | -1.2 |
| 30 Sept 2024 | Q3 | 0.0% | 0.0% | -13.8% | -9.8% | 0.03 | 3.54 | -1.1 |
| 30 Jun 2024 | Q2 | 100.0% | -30201.7% | -69.7% | -52.6% | 0.03 | 4.25 | -0.2 |
| 31 Mar 2024 | Q1 | -508.3% | -1061.3% | 58.1% | -19.6% | -0.26 | 0.72 | -2.1 |
| 31 Dec 2023 | Q4 | 93.5% | -31.9% | 68.3% | -8.4% | -0.59 | 0.90 | -3.2 |
| 30 Sept 2023 | Q3 | -12.7% | -98.8% | -113.3% | -14.3% | 0.54 | 1.62 | -2.3 |
| 30 Jun 2023 | Q2 | 100.0% | -267.7% | -88.4% | -20.0% | 0.29 | 1.98 | -1.8 |